Ipsen Biopharma Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ipsen Biopharma Limited

Patent Number:
Title:
Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect
Opposition Date:
Oct 26, 2022

Competitors of Ipsen Biopharma Limited

REVANCE THERAPEUTICS, INC.

Want to track Ipsen Biopharma Limited?

Feel free to send us a message here and we will get back to you